enVVeno Medical Corporation
Research enVVeno Medical Corporation (NVNO) on Bullrun: market cap USD 7.27M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNVNO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 7.27M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 3.60M
- Free cash flow-USD 3.55M
Valuation Snapshot
latest market cap is USD 7.27M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 19.47M | -USD 15.57M | n/a | -33.06 | USD 3.07M | USD 700.00K | USD 27.13M |
| FY2024 | USD 0 | -USD 21.82M | -USD 16.88M | n/a | -44.53 | USD 1.75M | USD 1.06M | USD 42.16M |
| FY2023 | n/a | -USD 23.52M | -USD 18.89M | n/a | -1.91 | USD 3.62M | USD 1.40M | USD 46.20M |
| FY2022 | n/a | -USD 24.67M | -USD 15.73M | n/a | -2.2 | USD 4.56M | USD 1.86M | USD 38.73M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 7.27M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.49M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 52.96M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 68.45M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 48.30M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 62.41M | n/a | n/a | n/a |
About enVVeno Medical Corporation
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is enVVeno Medical Corporation's market cap?
enVVeno Medical Corporation's market capitalization is USD 7.27M.
What does enVVeno Medical Corporation do?
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh.